362 related articles for article (PubMed ID: 15733544)
1. Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
Smulders CJ; Zwart R; Bermudez I; van Kleef RG; Groot-Kormelink PJ; Vijverberg HP
Eur J Pharmacol; 2005 Feb; 509(2-3):97-108. PubMed ID: 15733544
[TBL] [Abstract][Full Text] [Related]
2. Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs.
Zwart R; van Kleef RG; Gotti C; Smulders CJ; Vijverberg HP
J Neurochem; 2000 Dec; 75(6):2492-500. PubMed ID: 11080202
[TBL] [Abstract][Full Text] [Related]
3. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
Abin-Carriquiry JA; Voutilainen MH; Barik J; Cassels BK; Iturriaga-Vásquez P; Bermudez I; Durand C; Dajas F; Wonnacott S
Eur J Pharmacol; 2006 Apr; 536(1-2):1-11. PubMed ID: 16563372
[TBL] [Abstract][Full Text] [Related]
4. Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways.
Gopalakrishnan M; Molinari EJ; Sullivan JP
Mol Pharmacol; 1997 Sep; 52(3):524-34. PubMed ID: 9281615
[TBL] [Abstract][Full Text] [Related]
5. [3H]cytisine binding to nicotinic cholinergic receptors in brain.
Pabreza LA; Dhawan S; Kellar KJ
Mol Pharmacol; 1991 Jan; 39(1):9-12. PubMed ID: 1987453
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
Caricati-Neto A; D'angelo LC; Reuter H; Hyppolito Jurkiewicz N; Garcia AG; Jurkiewicz A
Eur J Pharmacol; 2004 Oct; 503(1-3):191-201. PubMed ID: 15496314
[TBL] [Abstract][Full Text] [Related]
7. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine.
Moroni M; Zwart R; Sher E; Cassels BK; Bermudez I
Mol Pharmacol; 2006 Aug; 70(2):755-68. PubMed ID: 16720757
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of nicotine- and acetylcholine-evoked currents through alpha4beta2 neuronal nicotinic receptors by tobacco cembranoids in Xenopus oocytes.
Eaton MJ; Ospina CA; Rodríguez AD; Eterović VA
Neurosci Lett; 2004 Aug; 366(1):97-102. PubMed ID: 15265598
[TBL] [Abstract][Full Text] [Related]
9. Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors.
Briggs CA; Gubbins EJ; Marks MJ; Putman CB; Thimmapaya R; Meyer MD; Surowy CS
Mol Pharmacol; 2006 Jul; 70(1):227-40. PubMed ID: 16569710
[TBL] [Abstract][Full Text] [Related]
10. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release.
Dajas-Bailador FA; Heimala K; Wonnacott S
Mol Pharmacol; 2003 Nov; 64(5):1217-26. PubMed ID: 14573772
[TBL] [Abstract][Full Text] [Related]
11. Physostigmine and galanthamine: probes for a novel binding site on the alpha 4 beta 2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells.
Pereira EF; Alkondon M; Reinhardt S; Maelicke A; Peng X; Lindstrom J; Whiting P; Albuquerque EX
J Pharmacol Exp Ther; 1994 Aug; 270(2):768-78. PubMed ID: 8071869
[TBL] [Abstract][Full Text] [Related]
12. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.
Samochocki M; Höffle A; Fehrenbacher A; Jostock R; Ludwig J; Christner C; Radina M; Zerlin M; Ullmer C; Pereira EF; Lübbert H; Albuquerque EX; Maelicke A
J Pharmacol Exp Ther; 2003 Jun; 305(3):1024-36. PubMed ID: 12649296
[TBL] [Abstract][Full Text] [Related]
13. Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity.
Texidó L; Ros E; Martín-Satué M; López S; Aleu J; Marsal J; Solsona C
Br J Pharmacol; 2005 Jul; 145(5):672-8. PubMed ID: 15834443
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the alpha9alpha10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-D-aspartate receptors.
Plazas PV; Savino J; Kracun S; Gomez-Casati ME; Katz E; Parsons CG; Millar NS; Elgoyhen AB
Eur J Pharmacol; 2007 Jul; 566(1-3):11-9. PubMed ID: 17466293
[TBL] [Abstract][Full Text] [Related]
15. Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects.
Zwart R; Vijverberg HP
Mol Pharmacol; 1997 Nov; 52(5):886-95. PubMed ID: 9351980
[TBL] [Abstract][Full Text] [Related]
16. Effects of dextrorotatory morphinans on alpha3beta4 nicotinic acetylcholine receptors expressed in Xenopus oocytes.
Lee JH; Shin EJ; Jeong SM; Kim JH; Lee BH; Yoon IS; Lee JH; Choi SH; Lee SM; Lee PH; Kim HC; Nah SY
Eur J Pharmacol; 2006 Apr; 536(1-2):85-92. PubMed ID: 16563374
[TBL] [Abstract][Full Text] [Related]
17. The acetylcholinesterase inhibitor BW284c51 is a potent blocker of Torpedo nicotinic AchRs incorporated into the Xenopus oocyte membrane.
Olivera-Bravo S; Ivorra I; Morales A
Br J Pharmacol; 2005 Jan; 144(1):88-97. PubMed ID: 15644872
[TBL] [Abstract][Full Text] [Related]
18. Chaperone protein 14-3-3 and protein kinase A increase the relative abundance of low agonist sensitivity human alpha 4 beta 2 nicotinic acetylcholine receptors in Xenopus oocytes.
Exley R; Moroni M; Sasdelli F; Houlihan LM; Lukas RJ; Sher E; Zwart R; Bermudez I
J Neurochem; 2006 Aug; 98(3):876-85. PubMed ID: 16787419
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of human alpha4beta2 neuronal nicotinic receptors by a Flustra foliacea metabolite.
Sala F; Mulet J; Reddy KP; Bernal JA; Wikman P; Valor LM; Peters L; König GM; Criado M; Sala S
Neurosci Lett; 2005 Jan; 373(2):144-9. PubMed ID: 15567570
[TBL] [Abstract][Full Text] [Related]
20. Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors.
Liu Q; Yu KW; Chang YC; Lukas RJ; Wu J
Acta Pharmacol Sin; 2008 Mar; 29(3):305-19. PubMed ID: 18298895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
